The weekly litigation news digest is live. Subscribe now
Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations - EP4005555
The patent EP4005555 was granted to Janssen Pharmaceutica on May 15, 2024. The application was originally filed on Nov 24, 2021 under application number EP21210307A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4005555
- Application Number
- EP21210307A
- Filing Date
- Nov 24, 2021
- Status
- Granted And Under Opposition
- Apr 12, 2024
- Publication Date
- May 15, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions (2)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (11) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents